Liver Cirrhosis: all 1,668 studies
Page 11 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- Mesenchymal Stem Cell Therapy for Liver CirrhosisStatus unknownNCT03626090Phase 1/2
- Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)Status unknownNCT03625726Not applicable
- Functional MRI to Determine Severity of CirrhosisStatus unknownNCT03623360
- Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver CirrhosisCompletedNCT03620474Phase 1/2
- Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral TherapyCompletedNCT03612973Not applicable
- Early Detection of Advanced Fatty Liver DiseaseCompletedNCT03608748
- The Effect of Calcium β-hydroxy-β-methylbutyrate (CaHMB) Supplementation in Sarcopenia in Liver CirrhosisStatus unknownNCT03605147Not applicable
- Liver Fibrosis in Peri-menopausal WomenStatus unknownNCT03602573
- Liver Steatosis and Stiffness in HIVStatus unknownNCT03599882
- Liver, Pancreas and Thyroid Function in Burn PatientsWithdrawnNCT03598283
- Dynamic Monitor of Portacaval Pressure GradientCompletedNCT03590288
- Copeptin Serum Level in Liver Transplant RecipientsCompletedNCT03587623
- Risk Factors and Outcomes of Acute Venous Thromboembolism in CirrhoticStatus unknownNCT03580577
- Meropenem Pharmacokinetics in Spontaneous Bacterial PeritonitisStatus unknownNCT03571711
- A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding BiomarkersStatus unknownNCT03568578Not applicable
- Tadalafil for Erectile Dysfunction in Patients With CirrhosisCompletedNCT03566914Not applicable
- First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver FibrosisCompletedNCT03559166Phase 1
- Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric SurgeryCompletedNCT03548597
- Management of Decompensated HCV Cirrhotic PatientsCompletedNCT03547895Not applicable
- Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan PatientsTerminatedNCT03539757
- Dose Effect Relationship of MTX and IBDCompletedNCT03531593
- Korean Cohort Study of AKI & HRS in CirrhosisStatus unknownNCT03530761
- Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver CirrhosisStatus unknownNCT03529136Phase 2
- Non-invasive Methods to Predict PHG in CirrhosisCompletedNCT03513900
- Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver CirrhosisCompletedNCT03513887
- ROLIVER - Prospective Cohort for the Identification of Liver MicrobiotaCompletedNCT03511573
- Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver InsufficiencyStatus unknownNCT03509194
- Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic CirrhosisTerminatedNCT03508388
- Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD TrialCompletedNCT03493204Not applicable
- Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases SeverityStatus unknownNCT03492879Not applicable
- Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis StageStatus unknownNCT03487159Not applicable
- MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)CompletedNCT03483272
- Iron Deficiency Anemia in Childern With Liver CirrhosisStatus unknownNCT03482076Not applicable
- Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or PlaceboTerminatedNCT03479125
- Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary CholangitisTerminatedNCT03476993Phase 2
- An Follow-Up Study of Liver CirrhosisCompletedNCT03472742
- Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM)Status unknownNCT03470389Not applicable
- Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary AtresiaCompletedNCT03468699Phase 2
- Outcome After TIPSCompletedNCT03459378
- Prevalence of Sarcopenia and Undernutrition in Patients With Cirrhosis and Abdominal HerniaCompletedNCT03458845
- The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver CirrhosisStatus unknownNCT03456440
- CT Portography in Grading of Liver CirrhosisStatus unknownNCT03453580
- AGRA Before and After Liver TransplantationActive, not recruitingNCT03446521
- A Study of Experimental Medication BMS-986036 Given to Healthy ParticipantsCompletedNCT03445208Phase 1
- Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive AssessmentCompletedNCT03443934
- MRI to Assess the Effect of Non-selective Beta-blocker in Patients With CirrhosisCompletedNCT03438916
- Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced CirrhosisStatus unknownNCT03437876Not applicable
- Restrictive Versus Liberal Red Blood Cell Transfusion in Patients of Cirrhosis With Septic ShockWithdrawnNCT03433508Not applicable
- Growth Hormone Therapy in Liver CirrhosisCompletedNCT03420144Phase 2/3
- Fecal Microbial Transplant for Alcohol Misuse in CirrhosisCompletedNCT03416751Phase 1
- G-CSF in Decompensated Cirrhosis: an Open Label TrialStatus unknownNCT03415698Phase 2/3
- Assessing Cirrhosis Quality of Care While Accounting for CostStatus unknownNCT03414398
- Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With CirrhosisCompletedNCT03407001Early Phase 1
- Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter StudyCompletedNCT03405909
- Vitamin D Level and Risk of Infections in Cirrhotic PatientsStatus unknownNCT03391245
- SWE Liver Stiffness as a Predictor of Progression of Chronic Liver DiseasesCompletedNCT03389152
- Propofol Versus Midazolam for Lower Gastrointestinal EndoscopyStatus unknownNCT03388151Phase 3
- Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver FibrosisStatus unknownNCT03386890
- Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) ElastographyCompletedNCT03382119
- Impact of Chlordecone on Active Chronic HepatitisCompletedNCT03373396Not applicable
- Radiomics-based Surrogate of Endoscopy (rEndosc) (CHESS1703)WithdrawnNCT03373123Not applicable
- Tips Underdilatation in Patients With CirrhosisStatus unknownNCT03363412Not applicable
- Effect of Coconut Milk Supplementation to Improve Nutritional Status in Cirrhosis PatientCompletedNCT03354299Not applicable
- Entecavir for Decompensated HBV CirrhosisCompletedNCT03345498
- Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRICompletedNCT03342703
- Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis?CompletedNCT03342170
- BCAA Supplemental StudyCompletedNCT03339232Not applicable
- In Vivo Determination of Cytochrome P450 Activities in Patients With Liver CirrhosisCompletedNCT03337945Not applicable
- ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO)Status unknownNCT03322696
- Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With CirrhosisCompletedNCT03318380Not applicable
- Low-Dose Danazol for the Treatment of Telomere Related DiseasesCompletedNCT03312400Phase 2
- Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary HypertensionWithdrawnNCT03309592Phase 4
- Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)Status unknownNCT03293953
- Influence of Shunt Occlusion on Organ Functions in Hyperammonemic Patients With Cirrhosis Having Porto-systemic Shunt.CompletedNCT03293459Not applicable
- Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular CarcinomaStatus unknownNCT03285867
- HMB for Denutrition in Patients With Cirrhosis (HEPATIC)CompletedNCT03285217Not applicable
- Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without RibavirinCompletedNCT03283176
- Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With CirrhosisActive, not recruitingNCT03278925Phase 1
- Noninvasive Diagnostic Platform for Liver Fibrosis and Portal HypertensionStatus unknownNCT03277651
- Changes in Lab and Ultrasonography After Endoscopic Varisceal TreatmentStatus unknownNCT03269786
- Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With AscitesCompletedNCT03263598
- A Study of ADR-001 in Patients With Liver CirrhosisCompletedNCT03254758Phase 1/2
- Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver DiseaseCompletedNCT03245606
- Assessment of Nutritional Status of Patients With Liver CirrhosisCompletedNCT03242798
- Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.Status unknownNCT03241823
- Effect of Vivomixx® on Neuroinflammation in Patients Withs CirrhosisWithdrawnNCT03236090Not applicable
- Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated CirrhosisCompletedNCT03236038
- Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1bStatus unknownNCT03222167Phase 3
- Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver CirrhosisStatus unknownNCT03209986Not applicable
- Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH CirrhosisStatus unknownNCT03205345Phase 2
- Bacterial Infections in Cirrhotic Patients With Acute Severe Liver InjuryStatus unknownNCT03204591
- Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume ParacentesisWithdrawnNCT03202524Phase 4
- Safety and Tolerability of Yaq-001 in Patients With CirrhosisTerminatedNCT03202498Not applicable
- Prevalence of Osteoporosis and Fractures in Patients With Hepatic Cirrhosis and Investigation of the Associated FactorsStatus unknownNCT03201016
- Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRICompletedNCT03198104
- WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver CirrhosisStatus unknownNCT03195634
- Evaluation of 'Melody' Paracentesis Device for Ascites TherapyCompletedNCT03191851Not applicable
- Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRIStatus unknownNCT03173287Not applicable
- Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory AscitesStatus unknownNCT03172273Not applicable
- Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic PatientsStatus unknownNCT03172013